BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 34032129)

  • 1. Therapeutic Challenges and Emerging Treatment Targets for Pulmonary Hypertension in Left Heart Disease.
    Lteif C; Ataya A; Duarte JD
    J Am Heart Assoc; 2021 Jun; 10(11):e020633. PubMed ID: 34032129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Under pressure: pulmonary hypertension associated with left heart disease.
    Farber HW; Gibbs S
    Eur Respir Rev; 2015 Dec; 24(138):665-73. PubMed ID: 26621980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension due to left heart diseases.
    Vachiéry JL; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs JS; Martinez F; Semigran M; Simonneau G; Wells A; Seeger W
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D100-8. PubMed ID: 24355634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension due to left heart disease.
    Vachiéry JL; Tedford RJ; Rosenkranz S; Palazzini M; Lang I; Guazzi M; Coghlan G; Chazova I; De Marco T
    Eur Respir J; 2019 Jan; 53(1):. PubMed ID: 30545974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group 2 Pulmonary Hypertension: Pulmonary Venous Hypertension: Epidemiology and Pathophysiology.
    Clark CB; Horn EM
    Cardiol Clin; 2016 Aug; 34(3):401-11. PubMed ID: 27443137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left Heart Disease and Pulmonary Hypertension: Are We Seeing the Full Picture?
    Chung K; Strange G; Codde J; Celermajer D; Scalia GM; Playford D
    Heart Lung Circ; 2018 Mar; 27(3):301-309. PubMed ID: 29102471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of combined pre- and post-capillary pulmonary hypertension in advanced heart failure with reduced ejection fraction.
    Sahay S; Khirfan G; Tonelli AR
    Respir Med; 2017 Oct; 131():94-100. PubMed ID: 28947049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular heart failure and pulmonary hypertension.
    Rosenkranz S; Gibbs JS; Wachter R; De Marco T; Vonk-Noordegraaf A; Vachiéry JL
    Eur Heart J; 2016 Mar; 37(12):942-54. PubMed ID: 26508169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension associated with left-sided heart disease.
    Maeder MT; Schoch OD; Kleiner R; Joerg L; Weilenmann D; Swiss Society For Pulmonary Hypertension
    Swiss Med Wkly; 2017; 147():w14395. PubMed ID: 28102878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Hypertension Due to Left Heart Disease-A Practical Approach to Diagnosis and Management.
    Lee F; Mielniczuk LM
    Can J Cardiol; 2021 Apr; 37(4):572-584. PubMed ID: 33217522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Hypertension Due to Left Heart Disease: Diagnosis, Pathophysiology, and Therapy.
    Al-Omary MS; Sugito S; Boyle AJ; Sverdlov AL; Collins NJ
    Hypertension; 2020 Jun; 75(6):1397-1408. PubMed ID: 32336230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diastolic Pressure Difference to Classify Pulmonary Hypertension in the Assessment of Heart Transplant Candidates.
    Wright SP; Moayedi Y; Foroutan F; Agarwal S; Paradero G; Alba AC; Baumwol J; Mak S
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension in left heart disease.
    Guazzi M; Galiè N
    Eur Respir Rev; 2012 Dec; 21(126):338-46. PubMed ID: 23204122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies.
    Haddad F; Kudelko K; Mercier O; Vrtovec B; Zamanian RT; de Jesus Perez V
    Prog Cardiovasc Dis; 2011; 54(2):154-67. PubMed ID: 21875514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary Vascular Disease: Hemodynamic Assessment and Treatment Selection-Focus on Group II Pulmonary Hypertension.
    Ramu B; Houston BA; Tedford RJ
    Curr Heart Fail Rep; 2018 Apr; 15(2):81-93. PubMed ID: 29417467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
    Yin J; Kukucka M; Hoffmann J; Sterner-Kock A; Burhenne J; Haefeli WE; Kuppe H; Kuebler WM
    Circ Heart Fail; 2011 Mar; 4(2):198-206. PubMed ID: 21216837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When Pulmonary Hypertension Complicates Heart Failure.
    Marra AM; Benjamin N; Cittadini A; Bossone E; Grünig E
    Heart Fail Clin; 2020 Jan; 16(1):53-60. PubMed ID: 31735315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of hospitalisations for heart failure and mortality in patients with pulmonary hypertension associated with left heart disease: a systematic review.
    Dzudie A; Kengne AP; Thienemann F; Sliwa K
    BMJ Open; 2014 Jul; 4(7):e004843. PubMed ID: 25011987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Hypertension secondary to Left Heart Disease.
    Kabbach G; Mukherjee D
    Curr Vasc Pharmacol; 2018; 16(6):555-560. PubMed ID: 28901848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension associated with left heart disease.
    Adir Y; Amir O
    Semin Respir Crit Care Med; 2013 Oct; 34(5):665-80. PubMed ID: 24037633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.